FDA and EMA have issued 10 guiding principles for AI in drug development with the intended goal of ensuring safety and ...
Jan 14 (Reuters) - The U.S. Food and Drug Administration and the European Medicines Agency jointly issued principles for safe ...
The guiding principles of good AI practice in drug development are a first step of a renewed EU-US cooperation.
Top of the list is that AIs must be human-centric by design and align with ethical values. They must be developed using a ...
GlobalData on MSN
FDA and EMA release collaborative AI framework for drug development
The joint guidance was created to ensure drug developers employ best practices when using AI.
EMA and FDA define ten principles for AI use in medicines – in response to growing pressure from the industry.
SHANGHAI, Nov. 3, 2025 /PRNewswire/ -- Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. (hereinafter referred to as "Sanyou Bio") and Shanghai ZJ Bio-Tech technology Co., Ltd. (hereinafter referred to ...
aims to advance oncology research by integrating computational design, medicinal chemistry, biology, medical science and ...
Hosted on MSN
AlphaFold opens new doors in drug development—how
AlphaFold, a transformative AI-driven tool developed by DeepMind, has revolutionized the field of structural biology by accurately predicting protein structures. This breakthrough holds significant ...
The United Nations Office on Drugs and Crime (UNODC), in close collaboration with the Iranian Drug Control Headquarters (DCHQ) and the Ministry of Health and Medical Education (MoHME), has held a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback